E-Newsletter: January 19, 2018

Happy New Year,

Earlier this week we took a day to celebrate Dr. Martin Luther King Jr.’s life and legacy of hope and healing.  It is a fact that we have indeed come a long way with an even longer way to go.  To that end it, it is no wonder why January is always a good month for behavioral reflections and starting something.

Take our first article; it shines a light on what could be a critical window of opportunity to explain why women tend to get Alzheimer’s more often than men due to the menopausal hormone changes that affect women’s brains.  It’s no secret that Menopause has been a known culprit for “brain fog” and/or loss of mental sharpness which could further aggravate cognitive problems.

Our second article covers the disappointing results of an extensive study performed with the medicine, intepirdine.  The medication was tested for 24 weeks in 1,315 women and men ages 50 to 85 with mild to moderate Alzheimer’s disease to no avail.

We will continue to work diligently to find a cure for Alzheimer’s!

Want to more information about Alzheimer’s; please visit our website at www.alzinfo.org.

During this New Year, it is my hope that you view the world with a positive rose colored perspective, speak your heart’s compassion with confidence, and listen to others to understand and find solutions.

Kent Karosen
President & CEO

Research Articles

Brain Changes of Menopause May Promote Alzheimer’s

January 17, 2018

The hormone changes that occur in a woman’s body during menopause may affect the brain in ways that increase the risk of developing Alzheimer’s disease, a new study reports. The findings could help explain in part why women tend to get Alzheimer’s more often than men do. Read More

Experimental Alzheimer’s Drug, Intepirdine, Disappoints in Study

December 12, 2017

Late-stage trials of an experimental drug called intepirdine showed disappointing Read More

We consistently receive top awards and ratings for our accountability: